Fatemeh Moosavi
Shiraz University of Medical Sciences
H-index: 11
Asia-Iran
Top articles of Fatemeh Moosavi
Study of Interactions of Nucleoside Anticancer Drugs, Capecitabine and Gemcitabine, with SWNT and BNNT using Molecular and Quantum Mechanical Calculations
Letters in Organic Chemistry
2024/3/1
Fatemeh Moosavi
H-Index: 6
Foretinib, a c-MET receptor tyrosine kinase inhibitor, tackles multidrug resistance in cancer cells by inhibiting ABCB1 and ABCG2 transporters
Toxicology and Applied Pharmacology
2024/2/15
Cytidine deaminase enzyme activity is a predictive biomarker in gemcitabine-treated cancer patients
Cancer Chemotherapy and Pharmacology
2023/12
Mehdi Dehghani
H-Index: 2
Shapour Omidvari
H-Index: 14
Fatemeh Moosavi
H-Index: 6
Omidreza Firuzi
H-Index: 28
Evaluation of the FDA-approved kinase inhibitors to uncover the potential repurposing candidates targeting ABC transporters in multidrug-resistant cancer cells: an in silico …
Journal of Biomolecular Structure and Dynamics
2023/10/30
Alireza Poustforoosh
H-Index: 0
Fatemeh Moosavi
H-Index: 6
Novel quinazoline-1, 2, 3-triazole hybrids with anticancer and MET kinase targeting properties
Scientific Reports
2023/9/6
5-Oxohexahydroquinolines bearing 4-pyridyl methyl carboxylate as P-glycoprotein inhibitors and multidrug resistance reversal agents in cancer cells
Journal of Molecular Structure
2023/8/5
Novel spiroindoline quinazolinedione derivatives as anticancer agents and potential FLT3 kinase inhibitors
Bioorganic & Medicinal Chemistry
2023/7/15
Therapeutic potential of quinazoline derivatives for Alzheimer's disease: A comprehensive review
2022/1/5
Study of the anticancer effect of new quinazolinone hydrazine derivatives as receptor tyrosine kinase inhibitors
Frontiers in Chemistry
2022/11/17
Prospects of targeting PI3K/AKT/mTOR pathway in pancreatic cancer
2022/8/1
Fatemeh Moosavi
H-Index: 6
Miriam Martini
H-Index: 19
Elisa Giovannetti
H-Index: 41
Omidreza Firuzi
H-Index: 28
In silico screening of c-Met tyrosine kinase inhibitors targeting nucleotide and drug-substrate binding sites of ABCB1 as potential MDR reversal agents
Journal of Receptors and Signal Transduction
2022/11/2
Fatemeh Moosavi
H-Index: 6
Tahereh Damghani
H-Index: 4
Combination of HGF/MET-targeting agents and other therapeutic strategies in cancer
2021/4/1
Antiproliferative effect, alteration of cancer cell cycle progression and potential MET kinase inhibition induced by 3, 4-dihydropyrimidin-2 (1H)-one C5 amide derivatives
European Journal of Pharmacology
2021
Imidazopyridine hydrazone derivatives exert antiproliferative effect on lung and pancreatic cancer cells and potentially inhibit receptor tyrosine kinases including c-Met
Scientific Reports
2021/2/11
